There are now known to be ϳ50 proteins in the human ABC 1 superfamily of transport proteins, and these have been divided into seven subfamilies (A through G) according to the relative similarities of their amino acid sequences (see on the World Wide Web, www.humanabc.org). Subfamily C of the human ABC superfamily consists of 12 proteins, seven of which are designated as MRPs (1) (2) (3) . MRP1, MRP2, MRP3, MRP6, and MRP7 have similar overall structures in that they each contain five domains: two NBDs and three MSDs, the latter containing up to 17 TM segments. The presence of the NH 2 -terminal MSD (MSD1) with its five TM helices and extracytosolic NH 2 terminus is a major structural feature distinguishing these ABCC proteins from the somewhat more distantly related cystic fibrosis transmembrane conductance regulator (CFTR), MRP4, MRP5, ABCC11, and ABCC12 (1, 2, 4, 5) . MRP1, MRP2, MRP3, and MRP6 also share the ability to transport conjugated organic anions (1, 3, 6) . However, whereas the substrate specificities of these MRP-related proteins are overlapping, they are not identical, and the affinity for a common substrate can vary quite markedly among the four transporters (1, 3, 6 -8) . The physiological functions of all of the MRP-related proteins are not yet fully understood. However, mutations in MRP2 (gene symbol ABCC2) are known to be responsible for Dubin-Johnson syndrome, which is characterized by conjugated hyperbilirubinemia (9 -12) , and mutations in MRP6 (gene symbol ABCC6) underlie the connective tissue disorder, pseudoxanthoma elasticum (13, 14) .
MRP1 (gene symbol ABCC1) was originally cloned from a multidrug-resistant small cell lung cancer cell line, and its expression has been detected in many human tumor cell lines that were either drug-selected or inherently resistant to a wide range of chemotherapeutic agents (15) (16) (17) . Introduction of MRP1 cDNA into cells confers increased resistance to many anticancer drugs and other xenobiotics including antimony and arsenic-centered oxyanions (1, 18, 19) . MRP1 is expressed in most normal tissues, and its murine ortholog has a demonstrated in vivo role in protecting certain organs from drug toxicity (20 -22) . MRP1 also transports oxidized and reduced glutathione (GSSG, GSH) as well as anionic GS, glucuronide, and sulfate conjugates of a diverse spectrum of endo-and xenobiotics (1, 17, (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) .
Well characterized endogenous organic anion substrates of MRP1 are the cysteinyl leukotriene LTC 4 and the conjugated estrogens, E 2 17␤G and E 1 3SO 4 (23) (24) (25) (26) (27) (28) (29) . GSH is a relatively low affinity substrate of MRP1, although transport of this tripeptide can be markedly stimulated by a variety of compounds, including various bioflavonoids, by a mechanism that is not fully understood (1, 31, (33) (34) (35) . Xenobiotic metabolites that are MRP1 substrates include the folic acid analog MTX as well as conjugates of the carcinogens aflatoxin B 1 and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (1, 8, 36 -38) . The specific amino acids that determine the ability of MRP1 to transport this exceptionally diverse spectrum of substrates remain largely unknown. Recently, however, several individual amino acids critical for the binding and transport of some MRP1 substrates and inhibitors have been identified (39 -46) . One of these is a highly conserved Trp residue at position 1246 predicted to be at or near the predicted membrane-cytoplasmic interface of the most COOH-proximal TM segment of the protein, TM17 (39) . Both conservative and nonconservative substitutions of this amino acid eliminated E 2 17␤G transport and resistance to cationic and electroneutral natural product drugs by MRP1. E 1 3SO 4 and MTX transport and sodium arsenite resistance were also significantly reduced by substitutions of Trp 1246 , but LTC 4 and GSH transport and antimony tartrate resistance remained essentially intact (39) . 2 Substitutions of the analogous tryptophan residues in TM17 of MRP2 and MRP3 (Trp  1254 and Trp  1242 , respectively) have also been subsequently shown to selectively affect the substrate specificity of these transporters but in a manner that is distinct for each protein (47, 48) . We have suggested that this Trp residue may be important in maintaining the architecture of a substrate binding pocket in the MRP-related proteins by serving a membrane anchoring function and participating in helix-helix interactions as well as possibly interacting directly with some substrates through the ability of its indole side chain to participate in H-bonding, cation-bonding, and aromatic stacking interactions (39, 47, 48) . In the present study, we have extended our investigations of the functional role of Trp residues in MRP1 by determining the functional consequences of mutating the remaining 11 Trp residues predicted to be in or near the TM helices of this transporter (Fig. 1) .
EXPERIMENTAL PROCEDURES
Materials- [6, 4 was purchased from Calbiochem, and nucleotides, GSH, apigenin, 2-mercaptoethanol, acivicin, E 2 17␤G, and dithiothreitol were purchased from Sigma.
Vector Construction and Site-directed Mutagenesis-Trp mutations in MRP1 were generated using the QuikChange TM site-directed mutagenesis kit (Stratagene, La Jolla, CA). The template for mutagenesis of Trp residues in MSD1 was prepared by cloning a 0.9-kb XbaI/BamHI fragment (containing nucleotides 1-841 of the MRP1 sequence encoding amino acids 1-280) from pcDNA3.1(Ϫ)-MRP1 K into pGEM-3Z7 (Promega, Madison, WI) (39) . The template for mutagenesis of Trp residues in MSD2 was prepared by cloning a 1.9-kb BamHI/SphI fragment (containing nucleotides 841-2701 encoding amino acids 281-900) from pcDNA3.1(Ϫ)-MRP1 K into pBluescriptSK(ϩ)7 (Stratagene, La Jolla, CA) into which a SphI site had been introduced into the multiple cloning site using the following mutagenesis primer (substituted nucleotides are underlined): 5Ј-CGACGGTATCGATAAGCATGCTATC-GAATTCCTGCAGC-3Ј. The template for mutagenesis of Trp 1198 in MSD3 was prepared by cloning a 2-kb XmaI fragment (containing nucleotides 2337-4323 encoding amino acids 780 -1440) from pcDNA3.1(Ϫ)-MRP1 K into pGEM-3Z7.
Tryptophan substitutions were generated in the pGEM-3Z and pBluescriptSK(ϩ) plasmids above according to the manufacturer's instructions with the following mutagenic primers (substituted nucleotides are underlined): MSD1 Trp mutants W40A (5Ј-G GTC CTC GTG  GCC GTG CCT TG-3Ј, W47A (5Ј-GT TTT TAC CTC GCC GCC TGT TTC  CCC-3Ј), W82A (5Ј-C TTG GGA TTT TTG CTG GCG ATC GTC TGC  TGG GC-3Ј), W86A (5Ј-G CTG TGG ATC GTC TGC GCT GCA GAC  CTC TTC TAC TC-3Ј), W94A (5Ј-C CTC TTC TAC TCT TTC GCG GAA  AGA AGT CGG GGC-3Ј), W142A (5Ј-GGG ATC ATG CTC ACT TTC  GCA CTG GTA GCC CTA ATG TG-3Ј), W142F (5Ј-G CTC ACT TTT  TTC CTG GTA GCC C-3Ј); MSD2 Trp mutants W361A (5Ј-C ACG AAG  GCC CCA GAT GCG CAG GGC TAC TTC TAC-3Ј), W445A (5Ј-G TAC  ATT AAC ATG ATC GCG TCA GCC CCC CTG CAA G-3Ј), W445F  (5Ј-CG TAC ATT AAC ATG ATC TTC TCA GCC CCC CTG CAA GTC-3Ј), W445Y (5Ј-CC ACG TAC ATT AAC ATG ATC TAC TCA GCG CCC  CTG CAA GTC-3Ј) , W459A (5Ј-GCT CTC TAC CTC CTG GCG CTG AAT CTG GGC CC-3Ј), W553A (5Ј-G GGC ACC TTC ACC GCG GTC TGC ACG CCC-3Ј), W553F (5Ј-G GGC ACC TTC ACC TTC GTC TGC ACG CCC-3Ј), W553Y (5Ј-GCC CTG GGC ACC TTC ACA TAT GTC TGC ACG CCC-3Ј; and MSD3 Trp mutants W1198A (5Ј-C GTG GCC AAC AGG GCG CTG GCC GTG CGG C-3Ј), W1198F (5Ј-GTG GCC AAC AGG TTC CTG GCC GTG CGG C-3Ј), W1198Y (5Ј-GTG GCC AAC AGG TAC CTG GCC GTG CGG C-3Ј). After confirming all mutations by sequencing or diagnostic restriction enzyme digests, the 0.9-kb XbaI/ BamHI fragment (MSD1 Trp mutants), the 1-kb BamHI/Bsu36I fragment (MSD2 Trp mutants), or the 1.3-kb BsmBI/EcoRI fragment (MSD3 Trp 1198 mutants) were subcloned back into pcDNA3.1(Ϫ)-MRP1 K , and the fragments in the full-length constructs were sequenced once again.
Construction of MRP1-GFP Fusion Proteins-Constructs encoding GFP fusion proteins of selected MRP1 Trp mutations were generated by exchanging the 1.3-kb ClaI/AflII fragment of a pcDNA3.1(Ϫ)-MRP1-GFP construct with the comparable fragments containing the W445A, W553A, and W1198A mutations generated above and designated pcDNA3.1-W445A/MRP1-GFP, pcDNA3.1-W553A/MRP1-GFP, and pcDNA3.1-W1198A/MRP1-GFP, respectively (39) .
Transfections of MRP1 Expression Vectors in Human Embryonic Kidney Cells-Wild-type and mutant pcDNA3.1(Ϫ)-MRP1 K expression vectors were transfected into SV40-transformed human embryonic kidney cells (HEK293T). In initial experiments, ϳ1.5 ϫ 10 5 cells were seeded in each well of a six-well plate and 24 h later were exposed to 1 g of DNA using FuGENEJ6 (Roche Diagnostics) according to the manufacturer's instructions. After 48 -60 h, the HEK cells were harvested, and crude membranes were prepared as before (24, 39, 49) . For membrane vesicle preparations, ϳ7 ϫ 10 6 cells were seeded per 15-cm dish and transfected 24 h later with 16 g of DNA using FuGENEJ6 as before. After 60 h, cells were harvested, and inside-out membrane vesicles were prepared as described previously (24) . Levels of wild-type and mutant MRP1 proteins were determined by immunoblotting as FIG. 1 . Location of Trp residues near or in the 17 predicted transmembrane segments of human MRP1. Shown is a schematic diagram of a secondary structure of MRP1 as predicted by the MEMSAT algorithm (68) . The approximate positions of the 11 Trp residues mutated in the present study are highlighted as is Trp 1246 , which was investigated previously (39) . Not shown are the remaining 18 non-membrane-associated Trp residues. described below. Empty vector and vector containing the wild-type MRP1 cDNA were included as controls in all experiments. Transfections were also carried out with a second independently generated clone of each mutant so that clonal variation could be excluded as an explanation for any changes in expression levels and/or transport activities observed.
Measurement of Protein Levels in Transfected Cells-The levels of wild-type and mutant MRP1 proteins were determined by immunoblot analysis of membrane vesicles prepared from transfected cells essentially as described (39 -43, 46) . Proteins were resolved on a 6 -7% polyacrylamide gel and electrotransferred to a nylon membrane. Blots were blocked with 4% (w/v) skim milk powder for 1 h followed by incubation with the human MRP1-specific monoclonal antibody QCRL-1 (diluted 1:10,000) (49, 50) . After washing, blots were incubated with horseradish peroxidase-conjugated goat anti-mouse antibody (Pierce) followed by application of Renaissance chemiluminescence blotting substrate (PerkinElmer Life Sciences) and exposure to film. Relative levels of protein expression were estimated by densitometry of multiple film exposures with a ChemiImagerJ 4000 (Alpha Innotech, San Leandro, CA).
MRP1-mediated Transport of 3 H-Labeled Substrates by Inside-out Membrane
Vesicles-Inside-out membrane vesicles were prepared from transfected HEK293 cells, and ATP-dependent uptake of 3 H-labeled substrates by the membrane vesicles was measured using a rapid filtration technique as described previously (24, 39 -43, 46 ). Briefly, [ 3 H]LTC 4 transport assays were performed at 23°C in a 50-l reaction containing 50 nM substrate (40 nCi/reaction), 4 mM ATP, 10 mM MgCl 2 , creatine phosphate (10 mM), creatine kinase (100 g ml Ϫ1 ), and 2-4 g of vesicle protein. Controls contained 4 mM AMP. In initial time course experiments, uptake was stopped at the indicated times and in subsequent experiments at 1 min by rapid dilution in ice-cold buffer, and then the reaction mixture was filtered through glass fiber (type A/E) filters that had been presoaked in transport buffer. Radioactivity was quantitated by liquid scintillation counting. All data were corrected for the amount of [ 3 H]LTC 4 that remained bound to the filter, which was usually 5-10% of the total radioactivity. Transport in the presence of AMP was subtracted from transport in the presence of ATP to determine ATP-dependent LTC 4 uptake. All transport assays were carried out in triplicate, and results were expressed as mean Ϯ S.D.). Uptake of [ 3 H]E 2 17␤G was measured in a similar fashion except that membrane vesicles (2 g of protein) were incubated at 37°C in a total reaction volume of 50 l containing E 2 17␤G (400 nM; 40 nCi) and components as described for LTC 4 transport. Initial time courses showed that [ 3 H]E 2 17␤G uptake was linear for 5 min, and consequently, subsequent uptake assays were stopped at 3 min.
[ 3 H]E 1 3SO 4 uptake was measured at 37°C for 1 min in a 50-l total reaction volume containing membrane vesicles (2 g of protein) and 300 nM [
3 H]E 1 3SO 4 (100 nCi) in the presence of 3 mM GSH and the same components as described above. [ 3 H]MTX uptake was measured as described previously with minor modifications (47, 51) . Assays were performed at 37°C in 50 l of transport buffer containing 1 M [ 3 H]MTX (250 nCi/reaction), 4 mM AMP or ATP, an ATP-regenerating system, and membrane vesicles (10 g of protein). Uptake was stopped at 20 min, diluted, and filtered as above. Apigenin-stimulated [ 3 H]GSH uptake was also measured by rapid filtration with membrane vesicles (20 g of protein) incubated at 37°C for 20 min in a 60-l reaction volume with 100 M [ 3 H]GSH (120 nCi/reaction) and apigenin added to 30 M (1, 33). To minimize GSH catabolism by ␥-glutamyl transpeptidase during transport, membranes were preincubated in 0.5 mM acivicin for 10 min at 37°C prior to measuring [ 3 H]GSH uptake (34) . All data were corrected for the amount of [ 3 H]GSH that remained bound to the filter. Confocal Microscopy-HEK293 cells transfected with the MRP1-eGFP constructs were seeded at 3.5 ϫ 10 5 cells/well in a six-well plate on coverslips coated with 0.1% gelatin in 2 ml of Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. Forty-eight h after transfection, the coverslips were washed once with PBS and fixed with 4% paraformaldehyde for 10 min at room temperature. After washing twice, cells were permeabilized by adding 0.2% Triton X-100. The coverslips were then incubated in RNase A (10 g ml Ϫ1 in 0.1% Triton X-100, 1% bovine serum albumin) for 60 min at room temperature. The coverslips were washed again, and cell nuclei were stained by incubation in 1 ml of propidium iodide (2 g ml Ϫ1 ) for 45 min in the dark. Finally, the coverslips were placed on slides containing 1 drop of Antifade Solution (Molecular Probes, Inc., Eugene, OR), and cells were examined and photographed using a Leica TCS SP2 MS multiphoton system confocal microscope (Leica Microsystems, Heidelberg, Germany).
RESULTS

Alanine Substitution of Tryptophan Residues in MSD1 Does
Not Affect Conjugated Organic Anion Transport by MRP1-In the first series of experiments, tryptophan residues at positions 40, 47, 82, 86, 94, and 142 predicted to be in the TM helices of MSD1 were replaced with alanine residues by site-directed mutagenesis and expressed in HEK293T cells. Inside-out membrane vesicles were prepared, and MRP1 protein expression levels were determined by immunoblotting. The levels of the W40A, W47A, W82A, W86A, and W94A mutant MRP1 proteins were comparable with that of wild-type MRP1 (range 75-100%). In contrast, levels of the W142A MRP1 mutant were ϳ35% (range 30 -40%) of wild-type MRP1 ( Fig. 2A) . Reduced expression levels of the W142A-MRP1 mutant were observed in multiple different transfection assays using several independently derived cDNA clones. 17␤G uptake was measured in the membrane vesicles from cells expressing the six Trp 3 Ala mutants of MSD1, the levels of uptake of both conjugated substrates were observed to be generally comparable with wild-type MRP1 when corrected for relative MRP1 expression levels (80 -140%) of wild-type MRP1 (Fig. 2,  B and C) . These results indicate that the nonconservative substitution of Trp residues in the TM segments of MSD1 with Ala does not have a significant deleterious effect on the transport of these two conjugated organic anions by MRP1.
Alanine Substitution of Selected Tryptophan Residues in MSD2 Eliminates
Organic Anion Transport by MRP1-We next replaced four Trp residues, which, according to at least one method of hydropathy analysis, are predicted to be near or in the TM segments of MSD2 (Fig. 1) . All four mutants generated (W361A, W445A, W459A, and W553A) were expressed at levels 60 -90% those of wild-type MRP1, indicating that none of the mutations had a major effect on the expression levels of the protein. A time course of [ 3 H]LTC 4 uptake was performed with membrane vesicles prepared from HEK cells expressing the MSD2 Trp 3 Ala mutants, and relative levels of uptake were determined (Fig. 3A) . After 1 min, ATP-dependent [
3 H]LTC 4 uptake by the W445A and W553A MRP1 mutants was reduced by ϳ75 and 50%, respectively, whereas uptake by the W361A and W459A mutants was comparable with wild-type MRP1 (Fig. 3B) . A time course of [ 3 H]E 2 17␤G uptake was also performed (Fig. 3C) . The ATP-dependent uptake rate of this substrate by the W459A MRP1 mutant, as for LTC 4 uptake, was comparable with that of wild-type MRP1 (Fig. 3C) . In contrast, after 1 min, [
3 H]E 2 17␤G uptake by the W361A, W445A, and W553A MRP1 mutants was ϳ50, 25, and 10%, respectively, of wild-type MRP1 (Fig. 3D) . These results indicate that Trp 445 , Trp 553 , and, to a lesser extent, Trp 361 are important for the conjugated organic anion transport function of MRP1.
To determine whether the Trp substitutions in MSD2 affected the transport of other MRP1 substrates, uptake of GSH, E 1 3SO 4 , and MTX was determined. GSH transport was measured in the presence of apigenin (30 M), which previous studies have shown markedly enhances the uptake of this tripeptide by MRP1, thereby allowing more accurate quantitation (1, 33) . As shown in Fig. 4A 361 and Trp 459 mutants was more moderately reduced to levels that were ϳ70 and 50% that of wild-type MRP1. Similarly, GSH-stimulated E 1 3SO 4 uptake levels by the W445A and W553A mutants were just 30 and Ͻ10% of wild-type MRP1 levels, respectively, whereas uptake by the W361A mutant was similar to wild-type MRP1, and uptake by W459A MRP1 was reduced by just 25% (Fig. 4B) . 
Finally, [
3 H]MTX uptake by the W445A and W553A MRP1 mutants, as observed for GSH and E 1 3SO 4 uptake, was dramatically reduced by more than 80% (Fig. 4C) . MTX uptake by the W361A mutant was also reduced (ϳ40%), whereas uptake by the W459A mutant was similar to that of wild-type MRP1. (Fig. 1) . We have previously shown that substitution of Trp 1246 at the cytosol-membrane interface of TM17 significantly alters the substrate specificity of MRP1 (39) . We have now examined the effects of substituting Trp 1198 , which is predicted to be at the membrane-cytosol interface of TM16. When expressed in HEK cells, W1198A-MRP1 was found to be expressed at levels that were ϳ35% (range 30 -40%) of those of wild-type MRP1, suggesting that MRP1 stability may be affected by this mutation. Time courses of [ 3 H]LTC 4 uptake showed that transport of this GSH-conjugated substrate by the W1198A mutant was ϳ65% of that by wild-type MRP1 after correcting for differences in MRP1 expression levels (Fig. 5A) . In contrast, ATP-dependent [ 3 H]E 2 17␤G uptake by the W1198A mutant was not detectable (Fig. 5B) . GSH, E 1 3SO 4 , and MTX uptake was also determined and, in all cases, was reduced by at least 80% (Fig. 5, C-E Can Selectively Restore the Transport Function of MRP1-To determine whether the loss of organic anion transport observed when the Trp residues at positions 445, 553, and 1198 were replaced with Ala could be attributed to the nonpolar nonaromatic and/or smaller size of the side chain of the substituting amino acid, mutants with more conservative substitutions at these positions with amino acids having nonpolar (Phe) and polar (Tyr) side chains were generated. These mutants were then expressed in HEK cells, and membrane vesicle preparations were tested for MRP1 expression levels ( Fig. 6A ) and organic anion transport activity as before (Fig. 6, B-F) . One mutant, W445Y, was reproducibly expressed at lower levels (approximately half) than the corresponding W445A and W445F mutants for reasons that are presently unclear.
The most conservatively substituted MRP1-Trp 445 mutant, W445Y, showed significant transport activity with respect to all five MRP1 substrates compared with the W445A mutant after correcting for differences in MRP1 expression levels. Thus, the LTC 4 and E 1 3SO 4 transport activities of W445Y MRP1 were similar to those of wild-type MRP1, whereas transport of E 2 17␤G, GSH, and MTX was 30 -60% of wild-type activity (Fig. 6, B-F) . The Phe-substituted Trp 445 mutant, W445F, showed levels of transport intermediate between those of the W445A and W445Y mutants. These results suggest that retaining the aromaticity of the amino acid side chain at position 445 is important for MRP1 transport activity and that additional activity is afforded by the presence of substituents with specific hydrogen bonding capabilities.
Transport activity of the W1198A MRP1 mutant was recovered to an even greater extent by Phe and Tyr substitutions. Thus, the LTC 4 , GSH, and E 1 3SO 4 transport activities of the W1198F mutant were similar to those of wild-type MRP1, whereas transport of these substrates by the W1198Y mutant exceeded that of wild-type MRP1 (Fig. 6, B, D, and E) . Transport of E 2 17␤G and MTX by the W1198F and W1198Y mutants was ϳ50 -75% that of wild-type MRP1 when corrected for relative MRP1 expression levels (Fig. 6, C and F) . For all substrates, transport activity was restored more effectively when Trp 1198 was mutated to Tyr compared with Phe, suggesting that, as observed for the Trp 445 mutants, both the aromatic and polar properties of the Trp residue at position 1198 contribute to MRP1 transport activity.
In contrast to the W445A and W1198A mutants, more conservative substitutions of the Ala-substituted Trp 553 mutant W553A were much less effective in restoring MRP1 transport activity. Thus, there were no significant differences among the Ala-, Tyr-, and Phe-substituted Trp 553 mutants with respect to uptake of LTC 4 , GSH, and MTX (Fig. 6, B, D, and F) . E 2 17␤G transport by the W553F and W553Y mutants was 50 and 25% that of wild-type MRP1, respectively (Fig. 6C) , and recovery of E 1 3SO 4 uptake by these mutants was modest (Ͻ30%) (Fig. 6E) . Thus, the transport activity of conservatively substituted MRP1-Trp 553 mutants was relatively poor and appeared selective for E 2 17␤G and, to a lesser extent, E 1 3SO 4 .
Transport Membrane of HEK Cells-To determine whether the decrease and/or elimination in transport activity caused by the Ala substitutions of the Trp residues at positions 445, 553, and 1198 might be associated with a change in the trafficking of MRP1 to the plasma membrane, the subcellular localization of GFPtagged mutant and wild-type MRP1 molecules was examined by laser-scanning confocal microscopy. As shown in Fig. 7 (52) . Thus, they are unusually abundant in MRP1, -2, -3, and -6, where they occur at a frequency of 1.7-2.0%. They also occur at a greater frequency in most subfamily C ABC transporters than they do in transporters belonging to other ABC subfamilies that are known to be involved in drug resistance. For example, in human P-glycoprotein (ABCB1) and BCRP (ABCG2) they occur at a frequency of Ͻ0.9%. Moreover, a recent study of murine P-glycoprotein in which all 11 Trp residues were mutated to Phe revealed that none of them are absolutely essential for the transport function of this protein (53) . The Trp-less P-glycoprotein mutant, however, exhibited a selective loss of FK-506 resistance, but no single Trp residue could be identified as being responsible for this altered phenotype. In contrast, our previous and present findings show that at least four of the 30 Trp residues in MRP1, Trp 445 , Trp 553 , Trp 1198 , and Trp 1246 , are significantly involved in determining its substrate specificity and transport activity (39) .
The orientation and the entry and exit amino acids of the up to 17 TM segments of MRP1 have not yet been precisely defined. However, analyses of hydropathy plots used to predict membrane protein topology place up to 12 Trp residues in or near the membrane cytosol interface of TM helices in all three MSDs of MRP1 (4, 54) . Consequently, these Trp residues are located in a position that could allow them to contribute to the optimal packing of TM helices for substrate translocation as well as having the potential to interact directly with at least some of the many substrates of this transporter. These are the Trp residues that we have investigated.
The NH 2 -proximal MSD1 of MRP1 contains ϳ200 amino acids, nine of which are Trp residues. Despite this unusually high frequency (4.5%), we found that none of the six singly Ala-substituted Trp mutants in the TM segments of this region showed significantly reduced E 2 17␤G or LTC 4 transport activity, and only one of them, W142A, was expressed at significantly lower levels than wild-type MRP1. This suggests that Trp 142 , which is located in TM4, may play a role in protein stabilization, perhaps by facilitating the proper folding and/or insertion of MRP1 in the membrane or else by promoting sta- bilizing interactions of TM4 with other domains of the transporter. In favor of this idea was our finding that expression levels of the conservatively substituted Trp 142 3 Phe mutant were comparable with wild-type MRP1, indicating that an aromatic side chain at this position is important for maintaining normal levels of MRP1 expression. Aromatic amino acids that contribute to membrane protein stability are frequently located at the distal ends of TM segments near the boundary between the hydrophilic and hydrophobic regions of the lipid bilayer (52, 55, 56) . However, this appears not to be the case for Trp 142 , since hydropathy analysis programs predict that this residue is located in the central region of TM4.
In contrast to MSD1, Ala substitution of the four Trp residues in MSD2 resulted in significant decreases in MRP1 transport activity, although all mutants were expressed at levels that were at least 50% of wild-type MRP1 levels. For the Ala-substituted Trp 361 and Trp 459 mutants, the effects were substrate-selective and relatively modest. Thus, the W361A mutant exhibited a 25-50% decrease in E 2 17␤G, GSH, and MTX transport activity compared with wild-type MRP1, but LTC 4 and E 1 3SO 4 transport activities were not affected. The W459A mutant displayed a slightly different phenotype in that its LTC 4 , E 2 17␤G, and MTX transport activities were similar to wild-type MRP1, but GSH and E 1 3SO 4 transport activities were reduced by 25-50%. In contrast, Ala substitutions of Trp 445 and Trp 553 caused a much broader and more extensive decrease in MRP1 transport activity. Thus, Ala substitution of Trp 445 essentially eliminated the transport of all five MRP1 substrates tested. Similarly, the transport of four MRP1 substrates by the W553A mutant was decreased by at least 80%, and transport of the fifth, LTC 4 , was reduced by ϳ50%. These results indicate that the four MSD2 Trp residues each have distinct roles in determining the substrate specificity and transport efficiency of MRP1.
There are some discrepancies with respect to the precise locations of the MSD2 Trp residues predicted by various algorithms used to generate models of membrane topology (54 LTC 4 , which was still transported at levels that were approximately half that of wild-type MRP1. The Ala-substituted Trp 1246 mutant, like W553A and W1198A, also showed significantly reduced transport of multiple MRP1 substrates with the exception of LTC 4 (39) . Trp 1198 is predicted to be located at the membrane-cytosol interface of TM16, and since there is evidence that consecutive TM segments in multispanning proteins are nearly always in contact with one another (57), this residue is likely to be in relatively close proximity to Trp 1246 , which is found at the membrane-cytosol interface of TM17 (39) . However, the specific environment of the two Trp residues appears to differ, since Tyr and Phe substitutions restore the transport activity of the W1198A but not W1246A mutant (39 (62) has shown that CFTR-Trp 202 , which is found in the third TM ␣-helix, resides on the water-accessible surface of this chloride channel and probably forms a portion of the channel lining. Several other residues in CFTR TM3 that are believed to line the channel are also conserved in the comparable TM8 of MRP1. These amino acid sequence similarities raise the possibility that Trp 445 in TM8, which like TM3 of CFTR is relatively rich in polar amino acids, may form a portion of the translocation pathway for the organic anion and amphipathic drug substrates of MRP1. At present, however, it is not known to what extent three-dimensional structures are conserved among ABCC subfamily members.
Alanine substitutions of aromatic residues in TM helices are considered to be cavity-creating mutations, since the spatial volume occupied by the Ala side chain is a great deal less than that occupied by the side chains of Trp, Phe, or Tyr. Moreover, since Trp residues often tend to cluster at the interface between the polar head group region and the hydrophobic interior of the lipid bilayer, their substitution with a nonaromatic nonpolar residue with a minimal side chain volume such as Ala can reduce the efficiency of proper membrane anchoring of the protein. This in turn can alter the positioning and effective hydrophobic length of the TM helix and thus disrupt the appropriate packing of TM segments necessary for substrate recognition and transport (63) . Tyr substitutions and, less frequently, Phe substitutions can sometimes correct Trp mutations of a more nonconservative, cavity-creating nature (64, 65) .
With respect to MRP1, the Phe-and Tyr-substituted Trp 445 and Trp 1198 mutants recovered some transport activity relative to the Ala-substituted mutants, with the extent of recovery being greater for the Tyr mutants for most substrates. These findings indicate that the steric bulk and aromaticity and, to a certain extent, the polarity of the indole side chains of these Trp residues contribute to tertiary interactions that determine the transport activity and also potentially the substrate specificity of MRP1. This does not appear to be the case for Trp 553 and Trp 1246 , where Tyr-and Phe-substituted mutants displayed phenotypes similar to those of the Ala-substituted mutants. Thus, the tertiary interactions of these two Trp residues appear quite stringent in their requirement for the indole side chain.
There are many examples of single spanning transmembrane proteins where the distribution of Trp residues can be quite asymmetric with respect to the two surfaces of the membrane, with an apparent tendency to cluster near the exterior surface (52, 55, 56) . In this position, they can play a critical role in membrane insertion, presumably by forming dipole-dipole, hydrogen-bonding, and/or stacking interactions within the lipid head group region. This asymmetry of Trp distribution is not readily apparent in MRP1, consistent with data base surveys that indicate that it is generally much less pronounced in multispanning membrane proteins. Thus, polytopic membrane proteins are believed to be more rigid and their membrane localization more strongly influenced by specific helix-helix interactions (52, 55, 56) . Nevertheless, it is of interest that the four Trp residues determined by our investigations to be the most critical for MRP1 transport activity are predicted to be located in the membrane (TM8-Trp 445 ) or at the membranecytosol interface of TM10 (Trp  553 ), TM16 (Trp  1198 ), and TM17  (Trp  1246 ) , where they are potentially in a position to interact directly with the anionic and amphipathic substrates of MRP1. Structural studies are needed to reveal the exact distribution and bonding interactions of the Trp residues of MRP1 so that their role in the transport mechanism and structure of this protein can be fully understood. Electron microscopy of purified reconstituted MRP1 has not yet provided images of sufficient resolution to allow such details to be determined (66) . However, the recently reported high resolution crystal structure of the bacterial ABC transporter, BtuCD, that mediates vitamin B 12 uptake suggests that such studies may be feasible in the not too distant future (67) .
